References
- Ahmed NN, Grimes HL, Bellacosa A, et al (1997). Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA, 94, 3627-32. https://doi.org/10.1073/pnas.94.8.3627
- Bellacosa A, Kumar CC, Di Cristofano A, et al (2005). Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res, 94, 29-86. https://doi.org/10.1016/S0065-230X(05)94002-5
- Blagden S, Gabra H (2009). Promising molecular targets in ovarian cancer. Curr Opin Oncol, 21, 412-9. https://doi.org/10.1097/CCO.0b013e32832eab1f
- Chan TO, Rittenhouse SE, Tsichlis PN (1999). AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem, 68, 965-1014. https://doi.org/10.1146/annurev.biochem.68.1.965
- Chin YR and Toker A (2001). Akt isoform-specific signaling in breast cancer: uncovering an anti-migratory role for palladin. Cell Adh Migr, 5, 211-4.
- Datta SR, Brunet A, Greenberg ME (1999). Cellular survival: a play in three Akts. Gene Dev, 13, 2905-27. https://doi.org/10.1101/gad.13.22.2905
- Fang R, Houghton PJ, Hylands PJ (2008). Cytotoxic effects of compounds from Iris tectorumon human cancer cell lines. J Ethnopharmacol, 118, 257–63. https://doi.org/10.1016/j.jep.2008.04.006
- Franke TF, Yang SI, Chan TO, et al (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell, 81,727-36. https://doi.org/10.1016/0092-8674(95)90534-0
- Han J (1988). Traditional Chinese medicine and the search for new antineoplastic drugs. J Ethnopharmacol, 24, 1-17. https://doi.org/10.1016/0378-8741(88)90135-3
- Hers I, Vincent EE, Tavare JM (2011). Akt signalling in health and disease. Cell Signal, 23,1515-27. https://doi.org/10.1016/j.cellsig.2011.05.004
- Lee KH (2010). Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach. J Nat Prod, 73, 500-16. https://doi.org/10.1021/np900821e
- Liu P, Cheng H, Roberts TM, et al (2009). Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov, 8, 627-44. https://doi.org/10.1038/nrd2926
- Lobenhofer EK, Huper G, Iglehart JD, et al (2000). Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ, 11, 99-110.
- Manning BD, Cantley LC (2007). AKT/PKB signaling: navigating downstream. Cell, 129, 1261-74. https://doi.org/10.1016/j.cell.2007.06.009
- Plas DR and Thompson CB (2005). Akt-dependent transformation: there is more to growth than just surviving. Oncogene, 24, 7435-42. https://doi.org/10.1038/sj.onc.1209097
- Rathmell JC, Fox CJ, Plas DR, et al (2003). Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol, 23, 7315-28. https://doi.org/10.1128/MCB.23.20.7315-7328.2003
- Sachsenmaier C (2001). Targeting protein kinases for tumor therapy. Onkologie, 24, 346-55. https://doi.org/10.1159/000055106
- Saif MW, Chu E (2010). Biology of colorectal cancer. Cancer J, 16,196-201. https://doi.org/10.1097/PPO.0b013e3181e076af
- Sarker D, Reid AH, Yap TA, et al (2009). Targeting the PI3K/ AKT pathway for the treatment of prostate cancer. Clin Cancer Res, 15, 4799-4805. https://doi.org/10.1158/1078-0432.CCR-08-0125
-
Seo AM, Hong SW, Shin JS, et al (2009). Sulindac induces apoptotic cell death in susceptible human breast cancer cells through, at least in part, inhibition of IKK
${\beta}$ . Apoptosis, 14, 913-22. https://doi.org/10.1007/s10495-009-0367-1 - Shin JS, Hong SW, Lee JG, et al (2011). An ethanol extract of Iris nertschinskia induces p53-dependent apoptosis in the MCF7 human breast cancer cell line. Int J Mol Med, 27, 401-5.
- Simpson L, Parsons R (2001). PTEN: life as a tumor suppressor. Exp Cell Res, 264, 29-41. https://doi.org/10.1006/excr.2000.5130
- Steinegger E, Hansel R (1988). Lehrbuch der Phamakognosie und Phytopharmazie. Springer, Berlin Heidelberg New York pp414-21.
- Soung YH, Lee JW, Nam SW, et al (2006). Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. Oncology, 70, 285-9. https://doi.org/10.1159/000096289
- Tan TL, Wen JJ (2001). Pharmaceutical achievement of ShenNongBenCiaoJing. Chin Pharm J, 36, 349–50.
- Vivanco I, Sawyers CL (2002). The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer, 2, 489-501. https://doi.org/10.1038/nrc839
- Wollenweber E, Stevens JF, Klimo K, et al (2003). Cancer chemopreventive in vitro activities of isoflavones isolated from Iris germanica. Planta Med, 69, 15-20. https://doi.org/10.1055/s-2003-37030
- Wong SM, Oshima Y, Pezzuto JM, et al (1986). Isolation and characterization of a new from Iris missouriensis. J Nat Prod, 49, 330-3. https://doi.org/10.1021/np50044a024
Cited by
- /M Phase and Growth Inhibition in SGC-7901 Gastric Cancer Cells vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6437
- Rana catesbeiana ribonuclease induces cell apoptosis via the caspase-9/-3 signaling pathway in human glioblastoma DBTRG, GBM8901 and GBM8401 cell lines pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3117